Related Experiment Video
Updated: Jan 13, 2026

08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
553
A MENage à Trois in leukemia.
1Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03755, USA.
Cancer Cell
|July 5, 2008
Summary
Menin protein is crucial for leukemia development by linking the MLL protein to LEDGF, a chromatin-associated factor. This discovery reveals a new target for treating MLL-related leukemias.
Area of Science:
- Molecular biology
- Cancer research
- Chromatin biology
Background:
- Menin protein interacts with the MLL protein, a key factor in certain leukemias.
- Oncogenic MLL fusion proteins are implicated in the development of leukemia.
- The precise role of menin in MLL-driven leukemogenesis requires further elucidation.
Purpose of the Study:
- To define the biochemical function of menin within the MLL complex.
- To identify critical protein interactions involving menin in the context of MLL fusion proteins.
- To uncover new therapeutic targets for MLL-related leukemias.
Main Methods:
- The study likely involved biochemical assays to investigate protein-protein interactions.
- Analysis of the MLL complex and its association with menin and other proteins.
- Investigating the role of menin in the transforming activity of MLL fusion proteins.
Main Results:
- Menin's essential function is to tether LEDGF (Lens Epithelium-Derived Growth Factor) to the MLL protein.
- LEDGF is identified as a critical chromatin-associated protein in MLL-related leukemias.
- Menin acts as a crucial linker, bringing together MLL and LEDGF within the complex.
Conclusions:
- Menin's primary role in leukemia is mediating the interaction between MLL and LEDGF.
- This interaction is essential for the oncogenic activity of MLL fusion proteins.
- Targeting the menin-LEDGF interaction could offer a novel therapeutic strategy for MLL-driven leukemias.
Related Concept Videos
Bone Marrow Sampling and Transplants
858
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
858
Disorders of Leukocytes
1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K

